more" /> more" /> more" />
PSP Society of Canada
PSP Society of Canada
Email
info@pspsocietycanada.ca
Call Now
1.888.675.0230
  • Home
  • About Us
  • Donate
  • Events
  • News
  • Educational Downloads
  • Volunteering

Article from Scientific American Supports Tau Protein as Key Player in Treatments for Neurodegeneration

Homepage News Article from Scientific American Supports Tau Protein as Key Player in Treatments for Neurodegeneration
News

Article from Scientific American Supports Tau Protein as Key Player in Treatments for Neurodegeneration

April 16, 2020
By admin
0 Comment
390 Views

The protein, once seen as a secondary player, has taken a leading role in combating neurodegenerative illnesses

Kingston — Thursday April 16th, 2020 — An article published in the Scientific American on March 2nd references years of research on the irregular buildup of the beta-amyloid and tau proteins in the brain leading to Alzheimer’s disease.

A lack of success studying the impact of beta-amyloid has now led to a shift in focus on tau.

New perspectives and additional efforts focused on the tau protein is welcome news to those involved in developing medicine for rare illnesses like PSP where toxic tau is a focal point of research.

Details:

Author: Karen Weintraub is a freelance health and science journalist who writes regularly for the New York Times, STAT and USA Today, among others.

Link: Tau Shows Promise as Achilles’ Heel for Alzheimer’s and Similar Diseases


Previous Story
The PSP Society of Canada Launches Annual Remembrance Program
Next Story
PSP Society of Canada Announces Toronto, ON Support Group

Related Articles

Research Validates Blood Test for Detecting Tau and Amyloid-B Pathologies

An analysis of consolidated data seeking new ways of accelerating...

MRI Biomarkers Distinguish Progressive Supranuclear Palsy from Idiopathic Normal Pressure Hydrocephalus

Kingston — Tuesday June 9th, 2020 — On May 14th,...

Recent Post

  • PSP Society of Canada Announces first ASK THE NEUROLOGIST SESSION Saturday, 8, Aug
  • Research Validates Blood Test for Detecting Tau and Amyloid-B Pathologies Wednesday, 24, Jun
  • MRI Biomarkers Distinguish Progressive Supranuclear Palsy from Idiopathic Normal Pressure Hydrocephalus Tuesday, 9, Jun
  • PSP Society of Canada Announces Recipe Program Wednesday, 3, Jun
  • $4 Million in Research Funding Awarded for Alzheimer’s, Frontotemporal Degeneration & other Tauopathies Such as PSP Monday, 1, Jun

Recent Comments

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Tags

    Disease foundation michael j fox Neurodegenerative Proteins Treatment

    About Us

    The PSP Society of Canada serves patients and families dealing with Progressive Supranuclear Palsy (PSP) and related diseases such as Multiple System Atrophy (MSA) and Corticobasal Degeneration (CBD).

     

    Click here to read about our framework for ethical collaboration with researchers, healthcare professionals & pharmaceutical companies.

    Contact Info

    Contact Us

    PO Box 40, Station Main
    Kingston, ON K7L 4V6

    1-888-675-0230

    info@pspsocietycanada.ca

    News

    • PSP Society of Canada Announces first ASK THE NEUROLOGIST SESSION Saturday, 8, Aug
    • Research Validates Blood Test for Detecting Tau and Amyloid-B Pathologies Wednesday, 24, Jun
    • MRI Biomarkers Distinguish Progressive Supranuclear Palsy from Idiopathic Normal Pressure Hydrocephalus Tuesday, 9, Jun

    Follow Us

    Follow Us on FacebookFollow Us on InstagramFollow Us on TwitterFollow Us on YouTube

     

     

    Programs

    Support Groups                      (REGISTER HERE)

    Annual Remembrances

    Physical Therapy for PSP

    PSP Recipe Program

    Educational Material

    Copyright ©2017 PSP Society of Canada. All Rights Reserved
    • Home
    • About Us
    • Donate
    • Events
    • Latest News
    • Educational Downloads
    • Volunteering
    Search